New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 29, 2014
08:47 EDTROSGRosetta Genomics announces research collaboration with Weizmann Institute
Rosetta Genomics announces that the company has entered into a collaborative research and license agreement with Yeda Research and Development Co. Ltd., the commercial arm of the Weizmann Institute of Science. The agreement involves collaboration with the Nancy and Stephen Grand Israel National Center for Personalized Medicine to develop novel methods for the preparation of next-generation sequencing libraries for small RNAs. The initial goals of this collaboration are to make this type of sequencing more cost effective as well as to minimize sequence-specific biases. The collaboration also aims at developing computational methods required for data analysis. The potential developed methods could allow more accurate quantification of microRNAs in various biological samples and pathological conditions.
News For ROSG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 30, 2015
09:18 EDTROSGRosetta Genomics announces partnership with FNApath
Rosetta Genomics announces that the company has reached an agreement-in-principle with FNApath of Little Rock, Arkansas, under which Rosetta Genomics will provide endocrinologists initially testing their patients for thyroid cancer with the option of using a pathologist or laboratory of their own choosing, or FNApath, a centralized laboratory with an expertise in diagnosing thyroid cancer. In the event of an indeterminate result, the sample would then be tested with RosettaGx Thyroid Reveal, the company's thyroid neoplasia assay for the differential diagnosis of indeterminate fine needle aspirates, or FNAs.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use